🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Influenza Multimeric-001 Vaccine

Found 8 matching trials

A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine

PHASE3

The pivotal Phase 3 trial plans to enroll a total of approximately 12,460 p...

Status

Completed

Location

Jagiellońskie Centrum Innowacji Sp.z o.o.

Start Date

2018-08-01

Trial ID

NCT03450915

Treatments Being Tested

M-001 Saline

A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers

PHASE2

"Multimeric-001" (M-001) has been recently developed, containing conserved,...

Status

Completed

Location

Hadassah medical center

Start Date

2011-08

Trial ID

NCT01419925

Treatments Being Tested

Two Multimeric-001 administrations followed by TIV One administration of Multimeric-001 followed by TIV One administration of adjuvanted M-001 followed by TIV One administration of placebo followed by TIV

Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001)

PHASE2

This is a multi-center, randomized, two stage, double-blind, placebo-contro...

Status

Completed

Location

Clinical Research Center, Hadassah Medical Center

Start Date

2010-07

Trial ID

NCT01146119

Treatments Being Tested

Multimeric-001, 500 mcg Adjuvanted PBS PBS and TIV 15%PBS and TIV 50%

Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV

PHASE2

This is a single-site, randomized, double-blind, placebo-controlled study o...

Status

Completed

Location

Clinical Research Center, Tel-Aviv Sourasky Medical Center

Start Date

2014-11

Trial ID

NCT02293317

Treatments Being Tested

M-001 TIV Saline

A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001)

PHASE1

A phase I/II, randomized, single-blind, placebo-controlled escalating doubl...

Status

Completed

Location

Tasmc Crc

Start Date

2009-06

Trial ID

NCT00877448

Treatments Being Tested

Adjuvanted Multimeric-001 250 Mcg Multimeric-001 250 Mcg Phosphate Buffered saline Adjuvanted PBS Adjuvanted Multimeric-001 500 Mcg Multimeric-001 500 Mcg Multimeric-001 125 Mcg

Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine

PHASE2

This is a Phase II randomized, double-blind, placebo-controlled trial in 12...

Status

Completed

Location

University of Iowa - Vaccine Research and Education Unit

Start Date

2018-04-09

Trial ID

NCT03058692

Treatments Being Tested

Influenza Multimeric-001 Vaccine Placebo Quadrivalent Recombinant Seasonal Influenza Vaccine

A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly Volunteers

PHASE1

This is a phase I/II, randomized, single-blind, placebo-controlled escalati...

Status

Completed

Location

Tasmc Crc

Start Date

2009-09

Trial ID

NCT01010737

Treatments Being Tested

Multimeric-001 250 mcg Adjuvanted Multimeric-001 250mcg Placebo Adjuvant: Montonide isa 51 VG Multimeric-001 500 mcg Adjuvanted Multimeric-001 500mcg TIV

Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults

PHASE2

"Multimeric-001" (M-001) contains conserved, common linear influenza epitop...

Status

Completed

Location

St Istvan St laszlo Hospital

Start Date

2015-11

Trial ID

NCT02691130

Treatments Being Tested

Multimeric 001 (M-001)H5N1 influenza vaccine Saline

Previous Next